IMATINIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11789LMP | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 2 | $189.48 | $31.60 | $31.60 |
| Available brands | |||||||
| Gilmata | |||||||
| Gliveca | |||||||
| IMATINIB RBXa | |||||||
| Imaniba | |||||||
| Imatinib Sandoza | |||||||
| Imatinib-Tevaa |
- Legend
- aBrand equivalent a
- MPMedical Practitioner




